I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
O'Dwyer, Peter J.
309
results:
Search for persons
X
Format
Online (309)
Mediatypes
Articles (Online) (199)
Bookchapter (Online) (1)
OpenAccess-fulltext (109)
Sorted by: Relevance
Sorted by: Year
?
1
Circulating KRAS G12D but not G12V is associated with survi..:
Till, Jacob E.
;
McDaniel, Lee
;
Chang, Changgee
...
Nature Communications. 15 (2024) 1 - p. , 2024
Link:
https://doi.org/10.1038/..
?
2
Combining antivascular endothelial growth factor and anti-e..:
Hochster, Howard S
;
Catalano, Paul
;
Weitz, Michelle
...
JNCI: Journal of the National Cancer Institute. , 2024
Link:
https://doi.org/10.1093/..
?
3
Targeting super-enhancers in refractory pancreatic cancer:
Propper, David
;
Borazanci, Erkut
;
Han, Haiyong
...
Pancreatology. 23 (2023) 4 - p. e5 , 2023
Link:
https://doi.org/10.1016/..
?
4
Phase II Study of Palbociclib (PD-0332991) inCCND1,2, or3Am..:
Clark, Amy S.
;
Hong, Fangxin
;
Finn, Richard S.
...
Clinical Cancer Research. 29 (2023) 8 - p. 1477-1483 , 2023
Link:
https://doi.org/10.1158/..
?
5
The NCI-MATCH trial: lessons for precision oncology:
O'Dwyer, Peter J.
;
Gray, Robert J.
;
Flaherty, Keith T.
...
Nature Medicine. 29 (2023) 6 - p. 1349-1357 , 2023
Link:
https://doi.org/10.1038/..
?
6
Ibrutinib combination therapy for advanced gastrointestinal..:
Oh, Do-Youn
;
Maqueda, Maria Alsina
;
Quinn, David I.
...
BMC Cancer. 23 (2023) 1 - p. , 2023
Link:
https://doi.org/10.1186/..
?
7
The New NCI Precision Medicine Trials:
Harris, Lyndsay N.
;
Blanke, Charles D.
;
Erba, Harry P.
...
Clinical Cancer Research. 29 (2023) 23 - p. 4728-4732 , 2023
Link:
https://doi.org/10.1158/..
?
8
Clinical and exploratory biomarker findings from the MODUL ..:
Ducreux, Michel
;
Tabernero, Josep
;
Grothey, Axel
...
European Journal of Cancer. 184 (2023) - p. 137-150 , 2023
Link:
https://doi.org/10.1016/..
?
9
Animal Models and Their Role in Imaging-Assisted Co-Clinica..:
Peehl, Donna M.
;
Badea, Cristian T.
;
Chenevert, Thomas L.
...
Tomography. 9 (2023) 2 - p. 657-680 , 2023
Link:
https://doi.org/10.3390/..
?
10
National Cancer Institute Combination Therapy Platform Tria..:
Meric-Bernstam, Funda
;
Ford, James M.
;
O'Dwyer, Peter J.
...
Clinical Cancer Research. 29 (2023) 8 - p. 1412-1422 , 2023
Link:
https://doi.org/10.1158/..
?
11
The GIANT trial (ECOG-ACRIN EA2186) methods paper: A random..:
Dotan, Efrat
;
Catalano, Paul
;
Lenchik, Leon
...
Journal of Geriatric Oncology. 14 (2023) 3 - p. 101474 , 2023
Link:
https://doi.org/10.1016/..
?
12
Phase 1 study of GSK3368715, a type I PRMT inhibitor, in pa..:
El-Khoueiry, Anthony B.
;
Clarke, James
;
Neff, Tobias
...
British Journal of Cancer. 129 (2023) 2 - p. 309-317 , 2023
Link:
https://doi.org/10.1038/..
?
13
Phase I Study of Glesatinib (MGCD265) in Combination with E..:
Patnaik, Amita
;
Gadgeel, Shirish
;
Papadopoulos, Kyriakos P.
...
Targeted Oncology. 17 (2022) 2 - p. 125-138 , 2022
Link:
https://doi.org/10.1007/..
?
14
Correction to: Phase I Study of Glesatinib (MGCD265) in Com..:
Patnaik, Amita
;
Gadgeel, Shirish
;
Papadopoulos, Kyriakos P.
...
Targeted Oncology. 17 (2022) 2 - p. 139-139 , 2022
Link:
https://doi.org/10.1007/..
?
15
Phase I Trial of Regorafenib, Hydroxychloroquine, and Entin..:
Karasic, Thomas B
;
Brown, Timothy J
;
Schneider, Charles
...
The Oncologist. 27 (2022) 9 - p. 716-e689 , 2022
Link:
https://doi.org/10.1093/..
1-15